Skip to main content
SCHOTT Pharma AG & Co. KGaA (ETR: 1SXP)
Germany flag Germany · Delayed Price · Currency is EUR
24.96
+0.20 (0.81%)
Dec 27, 2024, 5:35 PM CET

SCHOTT Pharma AG & Co. KGaA Revenue

In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M EUR with 6.51% growth. SCHOTT Pharma AG & Co. KGaA had revenue of 237.05M in the quarter ending September 30, 2024, with 3.73% growth.

Revenue
957.09M
Revenue Growth
+6.51%
P/S Ratio
3.83
Revenue / Employee
207.88K
Employees
4,646
Market Cap
3.67B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024957.09M58.49M6.51%
Sep 30, 2023898.60M77.46M9.43%
Sep 30, 2022821.14M172.48M26.59%
Sep 30, 2021648.67M64.44M11.03%
Sep 30, 2020584.23M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck KGaA 20.96B
Siemens Healthineers AG 22.36B
Bayer Aktiengesellschaft 46.74B
Fresenius SE & Co. KGaA 22.81B
Sartorius Aktiengesellschaft 3.32B
Fresenius Medical Care AG 19.24B
Carl Zeiss Meditec AG 2.07B
Fielmann Group AG 2.16B
Revenue Rankings

SCHOTT Pharma AG & Co. KGaA News

More News